Peptide Product Prices

# Peptide Product Prices: Industry Background and Basic Composition of Pricing Standards Peptide product pricing is not a simple figure but a dynamic system determined by multiple variables. Across different application scenarios such as peptide research reagents, cosmetic raw materials, and pharmaceutical intermediates, Peptide Product Prices can vary by dozens or even hundreds of times. Take a short peptide with only 5 amino acids as an example; its crude product may cost just a few RMB per milligram. In contrast, a 30-mer peptide with fluorescent labeling, phosphorylation modification and purity exceeding 98% can be quoted at hundreds of RMB per milligram. Such a massive price gap directly reflects the complexity of peptide product pricing standards. In terms of basic composition, peptide product pricing generally consists of four components: synthesis cost, purification cost, quality inspection cost, packaging and transportation cost. Synthesis cost is directly correlated with amino acid count and sequence complexity; purification cost depends on the target purity grade; quality inspection cost covers routine tests including HPLC and MS; packaging and transportation involve special requirements such as lyophilization and cold chain. Understanding this cost breakdown is the first step to judging whether a quotation is reasonable. Many buyers, when accessing peptide products for the first time, tend to focus only on the total price while ignoring the logic behind each cost module, which leads to subsequent budget deviations. Moreover, market supply and demand exert periodic impacts on peptide product pricing. For instance, during the research boom of GLP-1 peptide drugs, demand for synthesis of related sequences surged, delivery lead times were extended by some suppliers, and rush fees rose accordingly. Therefore, mastering the cost structure not only helps control procurement costs but also facilitates more favorable terms during negotiations. # Core Factors Affecting Peptide Product Prices Amino acid count is the most intuitive factor influencing peptide product pricing. In general, short peptides with sequences within 10 amino acids feature low synthesis difficulty and relatively affordable prices. When the sequence extends to 20–30 amino acids, coupling efficiency drops, by-products increase, purification difficulty rises sharply, and the price curve climbs steeply. According to public quotations from a supplier, a 10-mer peptide with 95% purity costs approximately 15 RMB per milligram, while a 30-mer peptide of the same purity may reach 60–80 RMB per milligram. This non-linear growth arises because each coupling reaction requires excess activated amino acids and coupling reagents, and raw material costs multiply with sequence length. Sequence complexity is equally critical. If a sequence contains multiple hydrophobic amino acids, consecutive arginine or histidine residues, or aggregation-prone fragments, synthesis difficulty increases substantially. Such sequences often require special technologies such as pseudoproline dipeptides and microwave-assisted synthesis, which directly push up Peptide Product Prices. In addition, if cysteine is present in the sequence, extra oxidative folding steps for disulfide bond formation must be considered, and this expense is usually listed separately. Purity grade serves as another decisive variable. Research-grade crude peptides, desalted peptides, and grades of 95%, 98% and even 99% purity — each upgrade requires more sophisticated preparative HPLC purification and brings lower recovery rates. Boosting purity from 95% to 98% represents only a three-percentage-point difference, yet purification costs may increase by 30% to 50%. Hence, purity is usually the primary metric for buyers to balance cost and performance in peptide procurement. # How Purity Grades Determine Peptide Product Prices Purity is the core indicator for evaluating peptide quality and the most flexible component in peptide pricing. Suppliers typically offer several standard purity tiers: crude peptide (~70%), desalted grade (~80%), >95% and >98%. Crude peptides have the lowest price and are suitable for preliminary screening or immunological experiments with loose purity requirements. In contrast, cell assays, receptor binding tests and animal studies usually demand purity above 95% to prevent impurities from interfering with experimental results. Take a 20-mer peptide as an example. Quotations from a domestic supplier show: crude peptide at around 5 RMB/mg, desalted grade at roughly 8 RMB/mg, 95% purity at 18 RMB/mg, and 98% purity at 28 RMB/mg. The price rises by more than 50% from 95% to 98% purity. This is because preparative HPLC requires finer gradient elution with narrower collection windows, and product recovery may plummet from 70% to below 40%. For high-volume projects, such cost differences will be greatly amplified. It is worth noting that purity labeling methods themselves can affect peptide pricing. Some suppliers report purity by HPLC peak area percentage, while others adopt mass percentage. The former may overestimate actual purity, whereas the latter is closer to the true content. When comparing quotations, buyers should clarify the purity detection method and evaluation criteria to avoid misjudgment caused by inconsistent standards. # Synthesis Scale and Price Tiering: From Milligram to Kilogram Scale The impact of synthesis scale on peptide pricing follows an obvious scale effect. At the milligram scale, fixed costs (such as resin, reagent initialization and QC testing) dominate, resulting in high unit prices. When production scales up to the gram level, unit prices usually drop by 30% to 50%. At kilogram scale or above, unit costs may further decrease to one-tenth or less of milligram quotations. This tiered pricing is the most economically significant feature of peptide product pricing standards. Specifically, a modified peptide quoted at 100 RMB/mg for milligram orders costs about 8,000 RMB for 100 mg. If purchasing 1 gram in a single batch, the unit price may fall to 40 RMB/mg with a total cost of approximately 40,000 RMB. Although total expenditure increases, the unit cost is greatly reduced. For long-term projects, bulk procurement with aliquot lyophilization is often more cost-effective than repeated small orders. Nevertheless, bulk procurement must take peptide stability and storage conditions into account to prevent degradation during long-term preservation. Furthermore, the scale effect does not extend infinitely in a linear fashion. Beyond a certain threshold, synthesis difficulty, purification load and quality control complexity also rise. Some special sequences cannot